FDA label 688f6471-00d5-47c6-8064-6de650e6455b
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 71438c2f-fdf7-451f-a7fd-bcf20f60fb90
- SPL ID
- 688f6471-00d5-47c6-8064-6de650e6455b
- Version
- 1
- Effective date
- 2010-10-27
- Source export date
- 2026-10-12
- Source partition
- 9
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/fb14b8f3d34b45230a84f851c029385f512adf3f002423a9b78d4f7ca626ecec/drug-label-0009-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:22:31
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 688f6471-00d5-47c6-8064-6de650e6455b | id | |
| spl set id | 71438c2f-fdf7-451f-a7fd-bcf20f60fb90 | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS Do not exceed recommended dosage. Do not take this product for persistent or chronic cough such as occurs with smoking, asthma, emphysema, or where excessive secretions accompany cough, except under the advice and supervision of a physician. A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache, consult a doctor.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Dextromethorphan Hydrobromide: occasionally causes slight drowsiness, dizziness, and gastrointestinal disturbances. Guaifenesin: Nausea and vomiting are the most frequently occurring side effects.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.